Eastgate Biotech Stock Forward View - Simple Moving Average
| ETBI Stock | USD 0.0008 0.00 0.000003% |
Eastgate Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Eastgate Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 4th of February 2026, the RSI of Eastgate Biotech's share price is approaching 31 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Eastgate Biotech, making its price go up or down. Momentum 31
Sell Stretched
Oversold | Overbought |
Using Eastgate Biotech hype-based prediction, you can estimate the value of Eastgate Biotech Corp from the perspective of Eastgate Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Eastgate Biotech Corp on the next trading day is expected to be 0.0008 with a mean absolute deviation of 0.0002 and the sum of the absolute errors of 0.01. Eastgate Biotech after-hype prediction price | USD 7.71E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Eastgate Biotech to cross-verify your projections. Eastgate Biotech Additional Predictive Modules
Most predictive techniques to examine Eastgate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eastgate using various technical indicators. When you analyze Eastgate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Eastgate Biotech Simple Moving Average Price Forecast For the 5th of February
Given 90 days horizon, the Simple Moving Average forecasted value of Eastgate Biotech Corp on the next trading day is expected to be 0.0008 with a mean absolute deviation of 0.0002, mean absolute percentage error of 0.0000004, and the sum of the absolute errors of 0.01.Please note that although there have been many attempts to predict Eastgate Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Eastgate Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Eastgate Biotech Stock Forecast Pattern
| Backtest Eastgate Biotech | Eastgate Biotech Price Prediction | Research Analysis |
Eastgate Biotech Forecasted Value
In the context of forecasting Eastgate Biotech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Eastgate Biotech's downside and upside margins for the forecasting period are 0.000008 and 162.85, respectively. We have considered Eastgate Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Eastgate Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Eastgate Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 99.7139 |
| Bias | Arithmetic mean of the errors | 1.0E-4 |
| MAD | Mean absolute deviation | 2.0E-4 |
| MAPE | Mean absolute percentage error | 1.2677 |
| SAE | Sum of the absolute errors | 0.0113 |
Predictive Modules for Eastgate Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eastgate Biotech Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Eastgate Biotech After-Hype Price Density Analysis
As far as predicting the price of Eastgate Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eastgate Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Eastgate Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Eastgate Biotech Estimiated After-Hype Price Volatility
In the context of predicting Eastgate Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eastgate Biotech's historical news coverage. Eastgate Biotech's after-hype downside and upside margins for the prediction period are 0.00 and 50.04, respectively. We have considered Eastgate Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Eastgate Biotech is out of control at this time. Analysis and calculation of next after-hype price of Eastgate Biotech Corp is based on 3 months time horizon.
Eastgate Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Eastgate Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eastgate Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eastgate Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
25.73 | 162.85 | 0.00 | 0.46 | 1 Events / Month | 2 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0008 | 0.0008 | 3.68 |
|
Eastgate Biotech Hype Timeline
Eastgate Biotech Corp is currently traded for 0.0008. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.46. Eastgate is forecasted to decline in value after the next headline, with the price expected to drop to 7.71E-4. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -3.68%, whereas the daily expected return is currently at 25.73%. The volatility of related hype on Eastgate Biotech is about 904722.22%, with the expected price after the next announcement by competition of 0.46. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be very soon. Check out Historical Fundamental Analysis of Eastgate Biotech to cross-verify your projections.Eastgate Biotech Related Hype Analysis
Having access to credible news sources related to Eastgate Biotech's direct competition is more important than ever and may enhance your ability to predict Eastgate Biotech's future price movements. Getting to know how Eastgate Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eastgate Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SCRCQ | ScripsAmerica | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CBDL | Cbd Life Sciences | 0.00 | 0 per month | 20.37 | 0.17 | 100.00 | (50.00) | 166.67 | |
| LRSV | Link Reservations | 0.00 | 1 per month | 0.00 | (0.18) | 0.00 | 0.00 | 33.33 | |
| TSTS | That Marketing Solution | 0.00 | 5 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FORZ | Forza Innovations | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GPFT | Grapefruit USA | 0.00 | 0 per month | 10.91 | 0.07 | 20.00 | (20.00) | 78.57 | |
| EMED | Electromedical Technologies | 0.00 | 1 per month | 17.21 | 0.14 | 100.00 | (50.00) | 150.00 | |
| DRWN | Quantum Medical Transport | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BSYI | Biosyntech | 0.54 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| QRON | Qrons Inc | (0.36) | 31 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Eastgate Biotech
For every potential investor in Eastgate, whether a beginner or expert, Eastgate Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eastgate Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eastgate. Basic forecasting techniques help filter out the noise by identifying Eastgate Biotech's price trends.Eastgate Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eastgate Biotech stock to make a market-neutral strategy. Peer analysis of Eastgate Biotech could also be used in its relative valuation, which is a method of valuing Eastgate Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Eastgate Biotech Market Strength Events
Market strength indicators help investors to evaluate how Eastgate Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eastgate Biotech shares will generate the highest return on investment. By undertsting and applying Eastgate Biotech stock market strength indicators, traders can identify Eastgate Biotech Corp entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 8.0E-4 | |||
| Day Typical Price | 8.0E-4 | |||
| Relative Strength Index | 31.8 |
Eastgate Biotech Risk Indicators
The analysis of Eastgate Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eastgate Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eastgate stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 108.91 | |||
| Standard Deviation | 369.69 | |||
| Variance | 136671.96 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Eastgate Biotech
The number of cover stories for Eastgate Biotech depends on current market conditions and Eastgate Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eastgate Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eastgate Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out Historical Fundamental Analysis of Eastgate Biotech to cross-verify your projections. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is there potential for Biotechnology market expansion? Will Eastgate introduce new products? Factors like these will boost the valuation of Eastgate Biotech. Projected growth potential of Eastgate fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Eastgate Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Eastgate Biotech Corp's market price often diverges from its book value, the accounting figure shown on Eastgate's balance sheet. Smart investors calculate Eastgate Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Eastgate Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Eastgate Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Eastgate Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Eastgate Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.